Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    131 - 140 out of 144Page size: 10
    1. 2010
    2. Published

      Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

      Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    3. Published

      Spontaneous Cytotoxic T cell Reactivity Against IDO Exists in Cancer Patients and in Healthy Donors

      Sørensen, R. B., Straten, P. T., Andersen, Mads Hald & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 910-911 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    4. Published

      Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

      Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    5. Published

      Therapeutic cancer vaccines

      Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. 2009
    7. Published

      Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56

      Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, S., Becker, J. C., Thor Straten, P., Andersen, Mads Hald, Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, Søren, Becker, J. C., Thor Straten, P. & Andersen, M. H., 1 Aug 2009, In: Journal of Investigative Dermatology. 129, 8, p. 1992-9 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

      Sørensen, R. B., Andersen, R. S., Svane, Inge Marie, Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, Mads Hald & thor Straten, P., 2009, In: Clinical Cancer Research. 15, 5, p. 1543-9 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"

      Sørensen, R. B., thor Straten, P. & Andersen, Mads Hald, 2009, In: Journal of Immunology. 183, 10, p. 6040 1 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

      Hofmann, U. B., Voigt, H., Andersen, Mads Hald, Straten, P. T., Becker, J. C. & Eggert, A. O., 2009, In: European Journal of Immunology. 39, 5, p. 1419-24 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. Published

      Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

      Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

      Hofmeister-Mueller, V., Vetter-Kauczok, C. S., Ullrich, R., Meder, K., Lukanidin, E., Broecker, E., Straten, P. T., Andersen, Mads Hald, Schrama, D. & Becker, J. C., 2009, In: Cancer Immunology, Immunotherapy. 58, 8, p. 1265-73 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1...10 11 12 13 14 15 Next

    ID: 13571778